Alaoui-Jamali MA - Search Results

1

Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer.

Morand GB, da Silva SD, Hier MP, Alaoui-Jamali MA. Morand GB, et al. Front Oncol. 2014 Nov 4;4:309. doi: 10.3389/fonc.2014.00309. eCollection 2014. Front Oncol. 2014. PMID: 25414832 Free PMC article. Review.

2

Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment.

Balys R, Alaoui-Jamali M, Hier M, Black M, Domanowski G, Rochon L, Jie S. Balys R, et al. J Otolaryngol. 2006 Jun;35(3):157-66. J Otolaryngol. 2006. PMID: 16929991

3

A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.

Mlynarek AM, Balys RL, Su J, Hier MP, Black MJ, Alaoui-Jamali MA. Mlynarek AM, et al. Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):910-8. doi: 10.1001/archotol.133.9.910. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17875858

4

Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.

Bijian K, Mlynarek AM, Balys RL, Jie S, Xu Y, Hier MP, Black MJ, Di Falco MR, LaBoissiere S, Alaoui-Jamali MA. Bijian K, et al. J Proteome Res. 2009 May;8(5):2173-85. doi: 10.1021/pr800979e. J Proteome Res. 2009. PMID: 19284786

5

Molecular insights on basal-like breast cancer.

Valentin MD, da Silva SD, Privat M, Alaoui-Jamali M, Bignon YJ. Valentin MD, et al. Breast Cancer Res Treat. 2012 Jul;134(1):21-30. doi: 10.1007/s10549-011-1934-z. Epub 2012 Jan 11. Breast Cancer Res Treat. 2012. PMID: 22234518 Review.

6

Recurrent oral cancer: current and emerging therapeutic approaches.

da Silva SD, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA. da Silva SD, et al. Front Pharmacol. 2012 Jul 30;3:149. doi: 10.3389/fphar.2012.00149. eCollection 2012. Front Pharmacol. 2012. PMID: 23060791 Free PMC article.

7

TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target.

da Silva SD, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. da Silva SD, et al. Cancer. 2014 Feb 1;120(3):352-62. doi: 10.1002/cncr.28404. Epub 2013 Oct 21. Cancer. 2014. PMID: 24150986 Free article.

8

Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.

Silva SD, Alaoui-Jamali MA, Hier M, Soares FA, Graner E, Kowalski LP. Silva SD, et al. Clin Exp Metastasis. 2014 Mar;31(3):307-16. doi: 10.1007/s10585-013-9629-y. Epub 2013 Dec 15. Clin Exp Metastasis. 2014. PMID: 24338375

9

Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.

da Silva SD, Morand GB, Alobaid FA, Hier MP, Mlynarek AM, Alaoui-Jamali MA, Kowalski LP. da Silva SD, et al. Clin Exp Metastasis. 2015 Jan;32(1):55-63. doi: 10.1007/s10585-014-9690-1. Epub 2014 Nov 30. Clin Exp Metastasis. 2015. PMID: 25433796

10

ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics.

Alaoui-Jamali MA, Morand GB, da Silva SD. Alaoui-Jamali MA, et al. Front Genet. 2015 Feb 4;6:17. doi: 10.3389/fgene.2015.00017. eCollection 2015. Front Genet. 2015. PMID: 25699077 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters